These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8389990

  • 1. Altered spectrum of retrogradely transported axonal proteins in p-bromophenylacetylurea neuropathy.
    Oka N, Brimijoin S.
    Neurochem Res; 1993 Jun; 18(6):675-80. PubMed ID: 8389990
    [Abstract] [Full Text] [Related]

  • 2. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea.
    Nagata H, Brimijoin S.
    Ann Neurol; 1986 May; 19(5):458-64. PubMed ID: 2424360
    [Abstract] [Full Text] [Related]

  • 3. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea.
    Jakobsen J, Brimijoin S.
    Brain Res; 1981 Dec 14; 229(1):103-22. PubMed ID: 6171326
    [Abstract] [Full Text] [Related]

  • 4. Premature onset of fast axonal transport in bromophenylacetylurea neuropathy: an electrophoretic analysis of proteins exported into motor nerve.
    Oka N, Brimijoin S.
    Brain Res; 1990 Feb 12; 509(1):107-10. PubMed ID: 1689602
    [Abstract] [Full Text] [Related]

  • 5. Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography.
    Oka N, Brimijoin WS.
    Mayo Clin Proc; 1992 Apr 12; 67(4):341-8. PubMed ID: 1372380
    [Abstract] [Full Text] [Related]

  • 6. Axonal transport in neuropathy.
    Jakobsen J, Brimijoin S, Sidenius P.
    Muscle Nerve; 1983 Feb 12; 6(2):164-6. PubMed ID: 6190080
    [Abstract] [Full Text] [Related]

  • 7. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
    Nagata H.
    Rinsho Shinkeigaku; 1990 Dec 12; 30(12):1355-7. PubMed ID: 1966015
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport.
    Nagata H, Brimijoin S.
    Brain Res; 1986 Oct 15; 385(1):136-42. PubMed ID: 2429734
    [Abstract] [Full Text] [Related]

  • 9. Acrylamide-induced increases in deposition of axonally transported glycoproteins in rat sciatic nerve.
    Harry GJ, Goodrum JF, Bouldin TW, Toews AD, Morell P.
    J Neurochem; 1989 Apr 15; 52(4):1240-7. PubMed ID: 2926398
    [Abstract] [Full Text] [Related]

  • 10. Vacor neuropathy: ultrastructural and axonal transport studies.
    Watson DF, Griffin JW.
    J Neuropathol Exp Neurol; 1987 Jan 15; 46(1):96-108. PubMed ID: 2432196
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: analysis by two-dimensional polyacrylamide gel electrophoresis.
    Logan MJ, McLean WG.
    J Neurochem; 1988 Jan 15; 50(1):183-9. PubMed ID: 2447233
    [Abstract] [Full Text] [Related]

  • 12. Reversal of axonal transport: similarity of proteins transported in anterograde and retrograde directions.
    Bisby MA.
    J Neurochem; 1981 Feb 15; 36(2):741-5. PubMed ID: 6162008
    [Abstract] [Full Text] [Related]

  • 13. Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.
    Brimijoin S, Mintz KP.
    Muscle Nerve; 1984 Feb 15; 7(9):725-32. PubMed ID: 6100457
    [Abstract] [Full Text] [Related]

  • 14. GAP 43-like immunoreactivity in normal adult rat sciatic nerve, spinal cord, and motoneurons: axonal transport and effect of spinal cord transection.
    Li JY, Kling-Petersen A, Dahlström A.
    Neuroscience; 1993 Dec 15; 57(3):759-76. PubMed ID: 8309535
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of axonal transport: are they a cause of peripheral nerve disease?
    Brimijoin WS.
    Mayo Clin Proc; 1982 Nov 15; 57(11):707-14. PubMed ID: 6182427
    [Abstract] [Full Text] [Related]

  • 16. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration.
    Gold BG, Griffin JW, Price DL.
    J Neurosci; 1985 Jul 15; 5(7):1755-68. PubMed ID: 2410575
    [Abstract] [Full Text] [Related]

  • 17. Synaptophysin immunoreactive axonal swelling in p-bromophenylacetylurea-induced neuropathy.
    Jortner BS, Dyer K, Walton A, Ehrich M.
    Neurotoxicology; 1997 Jul 15; 18(1):161-8. PubMed ID: 9215998
    [Abstract] [Full Text] [Related]

  • 18. Acrylamide neuropathy: changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons.
    Bisby MA, Redshaw JD.
    J Neurochem; 1987 Mar 15; 48(3):924-8. PubMed ID: 2433402
    [Abstract] [Full Text] [Related]

  • 19. Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea.
    Nagata H, Brimijoin S, Low P, Schmelzer JD.
    Brain Res; 1987 Oct 06; 422(2):319-26. PubMed ID: 2445441
    [Abstract] [Full Text] [Related]

  • 20. Pathology of the peripheral neuropathy induced by p-bromophenylacetylurea.
    Troncoso JC, Griffin JW, Price DL, Hess-Kozlow KM.
    Lab Invest; 1982 Feb 06; 46(2):215-23. PubMed ID: 7062723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.